Steketee G, Chambless D L, Tran G Q
School of Social Work, Boston University, MA 02215, USA.
Compr Psychiatry. 2001 Jan-Feb;42(1):76-86. doi: 10.1053/comp.2001.19746.
The impact of concurrent axis I diagnoses and axis II traits on the efficacy of a 22-session exposure-based treatment program for 43 outpatients with panic disorder and agoraphobia (PDA) and 63 with obsessive-compulsive disorder (OCD) was examined. Trained interviewers used the Structured Clinical Interview for DSM-III-R (SCID) to assess axis I diagnoses and the SCID-II to identify the number of axis II criteria met for anxious, dramatic, and odd clusters. Among axis I diagnoses, secondary major depressive disorder (MDD), dysthymia, social phobia, and generalized anxiety disorder (GAD) were present in sufficient numbers to study their effects on treatment outcome. Outcomes were assessed on self-rated target fears and functioning and on a behavioral avoidance test at post-treatment and at 6 months follow-up. Only GAD comorbidity predicted dropout, whereas MDD and all three personality cluster traits predicted post-treatment outcomes. Follow-up analyses showed significant effects of MDD and GAD, but axis II cluster criteria were not predictive.
研究了共病的轴I诊断和轴II特质对一项针对43名惊恐障碍伴广场恐惧症(PDA)门诊患者和63名强迫症(OCD)门诊患者的22节基于暴露疗法的治疗项目疗效的影响。经过培训的访谈者使用《精神疾病诊断与统计手册》第三版修订本(DSM-III-R)结构化临床访谈来评估轴I诊断,并使用SCID-II来确定符合焦虑、戏剧化和古怪类别的轴II标准数量。在轴I诊断中,继发性重度抑郁症(MDD)、心境恶劣障碍、社交恐惧症和广泛性焦虑障碍(GAD)的出现数量足以研究它们对治疗结果的影响。在治疗后和6个月随访时,通过自评目标恐惧和功能以及行为回避测试来评估结果。只有GAD共病预测了脱落率,而MDD和所有三种人格类别特质预测了治疗后结果。随访分析显示MDD和GAD有显著影响,但轴II类别标准无预测性。